Corp. Accbt serves as Executive at BRAINSTORM CELL THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Corp. Accbt has executed 15 insider transactions totaling $205.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 23, 2011 involved exercising options for 10,499,999 shares valued at $1.3M.
Corp. Accbt currently holds 29,006,924 shares of BRAINSTORM CELL THERAPEUTICS INC (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Corp. Accbt has been a net buyer of BCLI stock. They have purchased $205.7K and sold $0 worth of shares.
Corp. Accbt's most recent insider trade was on Jan 23, 2011, when they sold 10,499,999 shares at $0.12 per share.
Get notified when new Form 4 filings are submitted
| 4,125,000 |
| $0.18 |
| Discretionary |
| Apr 3, 2008 | BCLI | $360.0K | Option Exercise | 2,000,000 | $0.18 | Discretionary |
| Nov 12, 2007 | BCLI | $742.5K | Option Exercise | 4,125,000 | $0.18 | Discretionary |
| Sep 10, 2007 | BCLI | $0 | Option Exercise | 1,181,925 | $11819.00 | Discretionary |
| Aug 15, 2007 | BCLI | $4.8K | Purchase | 4,500 | $1.07 | Discretionary |
| Aug 15, 2007 | BCLI | $21.7K | Purchase | 20,500 | $1.06 | Discretionary |
| Aug 14, 2007 | BCLI | $22.1K | Purchase | 20,500 | $1.08 | Discretionary |
| Aug 13, 2007 | BCLI | $31.0K | Purchase | 29,500 | $1.05 | Discretionary |
| Aug 13, 2007 | BCLI | $16.8K | Purchase | 16,000 | $1.05 | Discretionary |
| Aug 10, 2007 | BCLI | $19.9K | Purchase | 20,500 | $0.97 | Discretionary |
| Aug 10, 2007 | BCLI | $13.5K | Purchase | 13,500 | $1.00 | Discretionary |
| Aug 10, 2007 | BCLI | $1.2M | Option Exercise | 6,875,000 | $0.18 | Discretionary |
| Aug 9, 2007 | BCLI | $8.7K | Purchase | 8,500 | $1.02 | Discretionary |
| Aug 9, 2007 | BCLI | $67.2K | Purchase | 66,500 | $1.01 | Discretionary |